Ocular Therapeutix News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.04.24	Ocular Therapeutix Reports Positive Phase 1 Data For Axpaxli In NPDR (RTTNews)
15.04.24	Ocular Therapeutix CEO Mattessich To Step Down, Dugel To Succeed (RTTNews)
19.02.24	AffaMed's Dextenza NDA Accepted In Singapore For Treating Ocular Inflammation And Pain (RTTNews)
14.12.23	Ocular Therapeutix Prices Public Offering At $3.25/share (RTTNews)
31.10.23	AffaMed Therapeutics Reports Positive Top-Line Results From Study Evaluating DEXTENZA (RTTNews)
31.10.23	AffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery (PR Newswire)
13.02.23	Pre-market Movers: GTHX, VLON, ZIVO, ACGN, OCUL… (RTTNews)
27.09.22	Ocular Therapeutix Reports Positive Interim Data From Phase 1 Trial Of OTX-TKI For Wet AMD (RTTNews)
13.04.22	AffaMed : Dextenza Approved In Macau For Treatment Of Ocular Inflammation After Ophthalmic Surgery (RTTNews)
13.04.22	AffaMed Therapeutics Announces New Drug Approval for DEXTENZA in Macau for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery (PR Newswire)
30.09.21	Biotech Stocks Facing FDA Decision In October 2021 (RTTNews)
14.10.20	Pre-market Movers In Healthcare Sector: MDRX, TLC, HGEN, ENLV, BNTX, ATEC... (RTTNews)
08.10.20	CDNA, OCUL Soar On Prelim Q3 Revenue, Lilly Seeks EUA For LY-CoV555 In COVID-19, ALKS On Watch (RTTNews)
07.10.20	Stock Alert: Ocular Therapeutix Touches New High (RTTNews)
04.03.20	INO On Track, MITO All Powered Up, TGTX Braces For Busy Year, COVID-19 Update (RTTNews)
11.11.19	Keep An Eye On ATNX, OCUL, SGMS… (RTTNews)
12.06.19	5 Top Gainers In Healthcare Sector (JAGX, CTRV, ZYNE...) (RTTNews)
22.05.19	5 Top Losers In Pharma Sector (BCRX, ONCS, OCUL...) (RTTNews)
26.11.18	Biotech Stocks Facing FDA Decision In December (RTTNews)
10.04.18	ABBV's SELECT-COMPARE Hits Goals, MNLO's ATOMIK Flops, VTVT Down 63% After-Hrs (RTTNews)
09.03.18	FDA Panel Backs Xeljanz For UC, ACRX Abuzz, AGLE Awaits Data This Month (RTTNews)
24.12.17	It's Raining FDA Approvals, SMMT Opens Wallet, AGRX Snubbed Yet Again (RTTNews)
19.12.17	CPSC Hails Successes of Virginia Graeme Baker Pool & Spa Safety Act as Law Hits 10-Year Mark (PR Newswire)
14.12.17	OCUL Catches Eyes, IMGN, CLLS Rise After ASH Data, Catalyst Ahead For RETA (RTTNews)
29.11.17	APEN Gains Steam, SGRY Starting To Heal, AZRX Catches Eyes, No Stopping CPRX (RTTNews)
28.11.17	CDNA, ALNA Up On Analyst Coverage, LIFE Goes Ahead, GLYC Gearing Up For ASH (RTTNews)
22.11.17	OSUR Turns Heads, MRSN To Report Data By Year-end, CYTK Loses Vitality (RTTNews)
17.11.17	Could Erectile Dysfunction Help Diagnose Diabetes in Men? (PR Newswire)
25.10.17	ATOS Catches Eyes, PTIE Gains, CNCE Hits Right Notes, SMMT Keeps Sliding (RTTNews)
31.08.17	EQUITY ALERT UPDATE: Rosen Law Firm Announces Filing of Securities Class Action Against Ocular Therapeutix, Inc. - OCUL (PR Newswire)
18.08.17	Biotech Stocks on Investors' Radar -- Ocular Therapeutix, Omeros, OvaScience, and Regulus Therapeutics (PR Newswire)
04.08.17	Gainers & Losers Of Aug.3: OMED, OSUR, PACB, AGRX, ELGX... (RTTNews)
02.08.17	FDA Nod For AGIO's IDHIFA, BMY Expands Opdivo Use, OCUL Reduces Headcount (RTTNews)
02.08.17	Ocular To Cut 26 Jobs Under Strategic Restructuring; Sees Charges In Q3 (RTTNews)
25.07.17	Block & Leviton Reminds Ocular Therapeutix, Inc. (OCUL) Shareholders Of Important Deadline In Securities Fraud Class Action And Encourages Them To Contact The Firm (PR Newswire)
25.07.17	OCUL Investors Update: Hagens Berman Alerts Investors in Ocular Therapeutix, Inc. to Expanded Class Period in Pending Securities Class Action, Reminds Them of the September 5, 2017 Lead Plaintiff... (PR Newswire)
21.07.17	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ocular Therapeutix, Inc. of Class Action Lawsuit and Upcoming Deadline - OCUL (PR Newswire)
19.07.17	OCULAR THERAPEUTIX ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Ocular Therapeutix, Inc. To Contact The Firm (PR Newswire)
19.07.17	Investor Alert: Kaplan Fox Announces Investigation Of Ocular Therapeutix, Inc. (PR Newswire)
13.07.17	Gainers & Losers Of July 12: CALA, TRVN, GEMP, ALDR, INSY... (RTTNews)
13.07.17	RM LAW Announces Class Action Lawsuit Against Ocular Therapeutix, Inc. (PR Newswire)
12.07.17	IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Ocular Therapeutix, Inc. and Encourages Investors with Losses to Contact the Firm (PR Newswire)
12.07.17	Ocular Therapeutix Climbs Off Lows But Continues To Post Steep Loss (RTTNews)
12.07.17	Biotech Stocks Ride Momentum in Anticipation of Favorable Governmental Policy Environment (PR Newswire)
12.07.17	Biotech Stocks Ride Momentum in Anticipation of Favorable Governmental Policy Environment (PR Newswire)
12.07.17	ORMP To Meet With FDA, Second Time's No Charm For OCUL, Panel Backs PFE (RTTNews)
12.07.17	Ocular Therapeutix Gets CRL For DEXTENZA (RTTNews)
11.07.17	Biotech Stock Performance Review -- NewLink Genetics, Ocera Therapeutics, Ocular Therapeutix, and Omeros (PR Newswire)
11.07.17	ARNA Heartened By Phase II Trial, BMY To Face FDA In Nov., Concert Back In Play (RTTNews)
11.07.17	Gainers & Losers Of July 10: KMPH, DOVA, AGLE, LMAT, OCUL... (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V

Nachrichten zu Ocular Therapeutix Inc

Aktien Top/Flop

Meistgelesene Nachrichten